Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > Pill form progress?
View:
Post by Maxmoe on Apr 09, 2021 12:57pm

Pill form progress?

I believe it's coming and needed to immunize big populations in lesser developed countries in Africa, and south east Asia. There are at least 2 other publicly listed companies pursuing a covid vaccine in pill form so why would anyone own vaxil for that? I've been patiently waiting for a capitulation blow off and/or a solid base before stepping in. 12 cents is looking like a solid base but now I'm wondering why bother if the main "hook" of covid pills, is being leapfrogged by others. What is the rationale, from a bull please, not a whining complainer. https://seekingalpha.com/news/3680347-immunitybio-posts-early-stage-interim-data-showing-potential-of-covid-19-vaccine
Comment by bligicka on Apr 09, 2021 3:40pm
Maybe....they should fix the vaccine first ???
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities